[Possible paths for influencing the mechanism of experimental silicosis].
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D002746:Chlorpromazine / Q000627:therapeutic use*; D003497:Cyclic N-Oxides / Q000627:therapeutic use; D008058:Dihydrolipoamide Dehydrogenase / Q000378:metabolism; D006854:Hydrocortisone / Q000627:therapeutic use*; D008264:Macrophages; D008928:Mitochondria / Q000201:enzymology; D009243:NAD; D009249:NADP; D010537:Peritoneum / Q000166:cytology; D011145:Polyvinyls / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D051381:Rats; D012829:Silicosis / Q000517:prevention & control*; D013385:Succinate Dehydrogenase / Q000378:metabolism; D014357:Trypsin / Q000627:therapeutic use*
D003497:Cyclic N-Oxides; D011145:Polyvinyls; D011725:Pyridines; D009243:NAD; D009249:NADP; D013385:Succinate Dehydrogenase; D008058:Dihydrolipoamide Dehydrogenase; D000135:Acid Phosphatase; D014357:Trypsin; D002746:Chlorpromazine; D006854:Hydrocortisone
Vozmozhnye puti vliianiia na mekhanizmy sklerozirovaniia pri silikoze v ékserimente.